Vertex Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
6,400
Employees6,400
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
6,400
Employees6,400

VRTX Key Statistics

Market cap
110.97B
Market cap110.97B
Price-Earnings ratio
28.66
Price-Earnings ratio28.66
Dividend yield
Dividend yield
Average volume
1.06M
Average volume1.06M
High today
$442.04
High today$442.04
Low today
$433.81
Low today$433.81
Open price
$440.71
Open price$440.71
Volume
776.99K
Volume776.99K
52 Week high
$510.77
52 Week high$510.77
52 Week low
$362.50
52 Week low$362.50

Stock Snapshot

As of today, Vertex Pharmaceuticals(VRTX) shares are valued at $434.45. The company's market cap stands at 110.97B, with a P/E ratio of 28.66.

As of 2026-04-23, Vertex Pharmaceuticals(VRTX) stock has fluctuated between $433.81 and $442.04. The current price stands at $434.45, placing the stock +0.1% above today's low and -1.7% off the high.

The Vertex Pharmaceuticals(VRTX)'s current trading volume is 776.99K, compared to an average daily volume of 1.06M.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $362.50 at its lowest and $510.77 at its peak.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $362.50 at its lowest and $510.77 at its peak.

VRTX News

Simply Wall St 18h
Does Upcoming Casgevy Gene-Editing Data Shift The Bull Case For Vertex Pharmaceuticals?

CRISPR Therapeutics recently highlighted several major clinical data readouts expected later in 2026 for its gene-editing programs, including candidates partner...

Does Upcoming Casgevy Gene-Editing Data Shift The Bull Case For Vertex Pharmaceuticals?
Simply Wall St 2d
A Look At Vertex Pharmaceuticals Valuation After Recent Share Price Weakness

Advertisement Context for Vertex Pharmaceuticals after recent share performance Vertex Pharmaceuticals (VRTX) has recently seen its share price under pressure...

A Look At Vertex Pharmaceuticals Valuation After Recent Share Price Weakness

Analyst ratings

76%

of 34 ratings
Buy
76.5%
Hold
17.6%
Sell
5.9%

People also own

Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.